Nant Capital LLC 13D/13G Filings for Panbela Therapeutics, Inc. (PBLA)

Nant Capital LLC 13D and 13G filings for Panbela Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-29
7:40 pm
Purchase
2024-10-2213DPanbela Therapeutics, Inc.
PBLA
Nant Capital LLC2,427,066
33.330%
2,427,066increase
(New Position)
Filing